Physician profile
Clark E Deshon
NPI 1861482309
$1,375.59
in general payments reported to CMS, 2019-2025
10 companies · $471 in 2025
The $471 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.61 · 2021: $58.61 · 2022: $300 · 2023: $82.85 · 2024: $369 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $683.52 | 2021-2025 | Precision 1, Total30, Precision7 |
| Bausch & Lomb Americas INC. | $163.95 | 2022-2025 | Infuse |
| Lkc Technologies, INC. | $102.70 | 2025 | |
| Dompe US, INC. | $101.78 | 2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $99.85 | 2022 | |
| Maculogix, INC. | $59.53 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $57.24 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $52.03 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Sight Sciences, INC. | $28.12 | 2024 | Omni Surgical System, Tearcare System |
| Coopervision INC. | $26.87 | 2023 | Clariti Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Deshon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.